SCHEMBL275233

SCHEMBL275233

[CH2]C1CCN(C)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1937046 0.89
SCHEMBL17796957 0.81
SCHEMBL17796938 0.81
SCHEMBL28245 0.81
SCHEMBL2735017 0.79 GNAI3 (0.50)
SCHEMBL19343096 0.76 GNAI3 (0.48)
SCHEMBL9965910 0.76 GNAI3 (0.48)
SCHEMBL6183469 0.74 GNAI3 (0.40)
SCHEMBL20047011 0.71 ALDH1A1 (0.50)
SCHEMBL19226519 0.71 GNAI3 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399206-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES Redona Therapeutics, Inc. (US) 2024-07-17 EP claimed
CN-118201914-A 4-Oxo-1, 4-dihydroquinoline-3-carboxylic acid derivatives as PAPD5 and/or PAPD7 inhibitors 雷多纳治疗公司 2024-06-14 CN claimed
CN-116969923-A Heteroaryl amino compounds, methods of preparation and use thereof 北京鞍石生物科技有限责任公司 2023-10-31 CN claimed
WO-2023138412-A1 FUSED PYRIMIDIN-2-AMINE COMPOUNDS AS CDK20 INHIBITORS INSILICO MEDICINE IP LIMITED (CN) 2023-07-27 WO claimed
US-11667635-B2 Bicyclic heterocycles as FGFR4 inhibitors INCYTE CORPORATION (US) 2023-06-06 US claimed
WO-2023039089-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES TWENTYEIGHT-SEVEN, INC. (US) 2023-03-16 WO claimed
CN-114787144-A Pyridone compounds and methods for modulating protein kinases 埃克塞里艾克西斯公司 2022-07-22 CN claimed
CN-114727983-A Xanthine CB1 inhibitors 金翅雀生物公司 2022-07-08 CN claimed
CN-110248939-B Tyrosine amide derivatives as RHO-kinase inhibitors 奇斯药制品公司 2022-05-17 CN claimed
EP-3256464-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2022-05-11 EP claimed
EP-0149840-B1 Substituted 5,11-dihydro-6H-dibenz[b,e]azepin-6-ones, method for their preparation and these compounds containing medicines Dr. Karl Thomae GmbH (DE) 1989-04-26 EP claimed
EP-0085899-B1 PYRIDOBENZODIAZEPINONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1986-10-29 EP claimed
EP-0085892-B1 SUBSTITUTED BENZODIAZEPINONES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1985-12-18 EP claimed
EP-0149840-A1 Substituted 5,11-dihydro-6H-dibenz[b,e]azepin-6-ones, method for their preparation and these compounds containing medicines Dr. Karl Thomae GmbH (DE) 1985-07-31 EP claimed
US-4447434-A ANTIULCER, ANTISECRETORY, OR ANTICHOLINERGIC AGENTS DR. KARL THOMAE GMBH (DE) 1984-05-08 US claimed
US-4424226-A ANTIULCER AGENTS DR. KARL THOMAE GMBH (DE) 1984-01-03 US claimed
US-4424225-A ANTIULCER AGENTS DR. KARL THOMAE GMBH (DE) 1984-01-03 US claimed
EP-0086982-A1 Substituted thienobenzodiazepinones, process for preparing them and medicines containing them Dr. Karl Thomae GmbH (DE) 1983-08-31 EP claimed
EP-0085899-A2 Pyridobenzodiazepinones, process for their preparation and pharmaceutical compositions containing them Dr. Karl Thomae GmbH (DE) 1983-08-17 EP claimed
EP-0085892-A1 Substituted benzodiazepinones, process for their preparation and medicines containing them Dr. Karl Thomae GmbH (DE) 1983-08-17 EP claimed